These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 1565143

  • 21. Tumors associated with p53 germline mutations: a synopsis of 91 families.
    Kleihues P, Schäuble B, zur Hausen A, Estève J, Ohgaki H.
    Am J Pathol; 1997 Jan; 150(1):1-13. PubMed ID: 9006316
    [Abstract] [Full Text] [Related]

  • 22. [When is it useful to look for TP53 germline gene mutations in families of oncology patients?].
    Trková M, Sedlácek Z.
    Cas Lek Cesk; 2003 Jan; 142(4):220-5. PubMed ID: 12841124
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Li-Fraumeni syndrome].
    Frebourg T.
    Bull Cancer; 1997 Jul; 84(7):735-40. PubMed ID: 9339200
    [Abstract] [Full Text] [Related]

  • 25. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.
    Marx SJ, Agarwal SK, Kester MB, Heppner C, Kim YS, Skarulis MC, James LA, Goldsmith PK, Saggar SK, Park SY, Spiegel AM, Burns AL, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Emmert-Buck MR, Guru SC, Manickam P, Crabtree J, Erdos MR, Collins FS, Chandrasekharappa SC.
    Recent Prog Horm Res; 1999 Jul; 54():397-438; discussion 438-9. PubMed ID: 10548885
    [Abstract] [Full Text] [Related]

  • 26. Mutation spectrum of the p53 gene in bone and soft tissue sarcomas.
    Toguchida J, Yamaguchi T, Ritchie B, Beauchamp RL, Dayton SH, Herrera GE, Yamamuro T, Kotoura Y, Sasaki MS, Little JB.
    Cancer Res; 1992 Nov 15; 52(22):6194-9. PubMed ID: 1423262
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
    Ruijs MW, Verhoef S, Rookus MA, Pruntel R, van der Hout AH, Hogervorst FB, Kluijt I, Sijmons RH, Aalfs CM, Wagner A, Ausems MG, Hoogerbrugge N, van Asperen CJ, Gomez Garcia EB, Meijers-Heijboer H, Ten Kate LP, Menko FH, van 't Veer LJ.
    J Med Genet; 2010 Jun 15; 47(6):421-8. PubMed ID: 20522432
    [Abstract] [Full Text] [Related]

  • 31. Predominantly tumor-limited expression of a mutant allele in a Japanese family carrying a germline p53 mutation.
    Horio Y, Suzuki H, Ueda R, Koshikawa T, Sugiura T, Ariyoshi Y, Shimokata K, Takahashi T, Takahashi T.
    Oncogene; 1994 Apr 15; 9(4):1231-5. PubMed ID: 8134126
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
    Malkin D, Chilton-MacNeill S, Meister LA, Sexsmith E, Diller L, Garcea RL.
    Oncogene; 2001 Jul 27; 20(33):4441-9. PubMed ID: 11494139
    [Abstract] [Full Text] [Related]

  • 34. Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers.
    Nichols KE, Malkin D, Garber JE, Fraumeni JF, Li FP.
    Cancer Epidemiol Biomarkers Prev; 2001 Feb 27; 10(2):83-7. PubMed ID: 11219776
    [Abstract] [Full Text] [Related]

  • 35. A method for estimating cancer risk in p53 mutation carriers.
    Le Bihan C, Bonaiti-Pellie C.
    Cancer Detect Prev; 1994 Feb 27; 18(3):171-8. PubMed ID: 8076379
    [Abstract] [Full Text] [Related]

  • 36. Screening for germ line p53 mutations in children with malignant tumors and a family history of cancer.
    Brugières L, Gardes M, Moutou C, Chompret A, Meresse V, Martin A, Poisson N, Flamant F, Bonaïti-Pellié C, Lemerle J.
    Cancer Res; 1993 Feb 01; 53(3):452-5. PubMed ID: 8425176
    [Abstract] [Full Text] [Related]

  • 37. p53 mosaicism with an exon 8 germline mutation in the founder of a cancer-prone pedigree.
    Kovar H, Auinger A, Jug G, Müller T, Pillwein K.
    Oncogene; 1992 Nov 01; 7(11):2169-73. PubMed ID: 1359493
    [Abstract] [Full Text] [Related]

  • 38. Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer.
    Lehman TA, Haffty BG, Carbone CJ, Bishop LR, Gumbs AA, Krishnan S, Shields PG, Modali R, Turner BC.
    Cancer Res; 2000 Feb 15; 60(4):1062-9. PubMed ID: 10706125
    [Abstract] [Full Text] [Related]

  • 39. Three germline mutations in the TP53 gene.
    Cornelis RS, van Vliet M, van de Vijver MJ, Vasen HF, Voute PA, Top B, Khan PM, Devilee P, Cornelisse CJ.
    Hum Mutat; 1997 Feb 15; 9(2):157-63. PubMed ID: 9067756
    [Abstract] [Full Text] [Related]

  • 40. Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumours: molecular and immunohistochemical findings.
    Eeles RA, Warren W, Knee G, Bartek J, Averill D, Stratton MR, Blake PR, Tait DM, Lane DP, Easton DF.
    Oncogene; 1993 May 15; 8(5):1269-76. PubMed ID: 8479749
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.